Pharmacologic changes in performance of normal and brain-damaged rats.
D000818:Animals; D001921:Brain / Q000033:anatomy & histology; D002395:Catecholamines / Q000502:physiology; D002540:Cerebral Cortex / Q000502:physiology; D002746:Chlorpromazine / Q000494:pharmacology*; D003216:Conditioning, Operant / Q000187:drug effects / Q000502:physiology*; D010134:Fenclonine / Q000494:pharmacology; D006624:Hippocampus / Q000502:physiology*; D008297:Male; D018377:Neurotransmitter Agents / Q000502:physiology*; D010830:Physostigmine / Q000494:pharmacology; D051381:Rats; D012055:Reinforcement Schedule; D012701:Serotonin / Q000502:physiology; D013997:Time Factors; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors
D002395:Catecholamines; D018377:Neurotransmitter Agents; D012701:Serotonin; D010830:Physostigmine; D014446:Tyrosine 3-Monooxygenase; D010134:Fenclonine; D002746:Chlorpromazine